View this email in your browser

Hello!

I hope you have had a great start in 2021 so far. COVID and political unrest are still present, but it's my hope that the past few weeks have been a radical crescendo signaling that the worst is behind us. Hoskin Capital UpdateAt Hoskin Capital, the mood is optimistic to say the least. We have started 2021 off with a bang and we are planning to continue the momentum all the way through New Year's 2022! Thanks to a slew of new investors, we have doubled our assets under management in the first two weeks of January. We found some of these investors in an unlikely place: TikTok! We started the HC TikTok on January 1 as a way to educate more people about investing, retirement, and financial planning. We set a goal of hitting 1,000 followers by June, but we gained over 12,000 followers in just 11 days! These last few weeks have been successful for our current clients as well. In the last 30 days, Hoskin Capital's funds have returned an aggregate of 7.81%. That's more than double the returns of the S&P 500 in the same period. Since we started in late November, we have returned a total of 9.82% compared to the S&P's 5.98%.Returns come and go, and I fully expect the market to catch up with us at some point. The reason I'm so proud of this achievement is that we managed to do it without holding a single irresponsible company. Oil, coal, and gas companies were by far the best performers in the last months of 2020 (outperformed every other industry by more than 20%) and drove our benchmark to record highs. We were able to beat the market with 0 investment in this industry!WinnersWe can credit our returns to a few investments that have done incredibly well in the past few months. 1. ALPS Clean Energy ETF (ACES) - We have held ACES in our Climatic fund since its inception and so far it has returned +37%. This ETF invests exclusively in companies providing clean energy sources and uses for clean energy. We love it and will continue to hold it. 2. Crispr Therapeutics (CRSP) - CRISPR stands for "clustered regularly interspaced short palindromic repeats" and is a DNA sequence that allows cells to detect and destroy infectious bacteria and viruses. Crispr Therapeutics is using CRISPR to develop a gene-editing technology. They aim to cure previously impossible illnesses like Sickle-Cell Anemia. The possibility of curing chronic illnesses put the company at the top of our impact list. Since our investment, the company has returned +57%. We also bought their two competing companies, Intellia Therapeutics (NTLA, +40%) and Editas Medicine (EDIT, +5.9%).3. Lemonade, Inc. (LMND) - Lemonade is a fully digital insurance provider that offers homeowner's, renter's, and pet insurance. They are a social impact company and a registered B-Corp. They are the first insurance company to handle applications, underwriting, and claims through mobile apps. They are looking to expand their offerings into auto, health, and life insurance. So far we're up +50%.LosersFor every winner, there is often a loser. Our portfolio was no different.Carnival Cruise Lines (CCL) - We bought Carnival because we believed the worst of COVID was behind us and we would see a return to damaged industries (leisure, travel, dining). We were very wrong and cut our losses at -10%. Fluor Corp (FLR) - Fluor is an engineering and construction company that we believe will receive the first contract when the Biden administration kicks off the "Great American Remodel" and begins repairing roads and buildings. We still see promise in this company, but we stopped our losses at -10% in late December.Beyond Meat (BYND) - This alternative meat provider is a personal favorite of mine, and because of my attachment, it remained in our portfolio long after it had shown its weakness. It fell -10% in mid-December and I added to the position. It climbed for a short while before returning to the -10% mark. I finally closed the position with losses of about -14%.   Our 2021 OutlookAs we move into 2021, we are continuing to benefit from many of our holdings, but we expect to see investor demand shift away from these companies and into damaged parts of the economy. For the past few months, the focus on technology companies has shifted to banks, retail stores, and industrials (building products, machinery, etc). In the first three months of 2021, we expect the focus to shift again to benefit from the recovery of commercial real estate, restaurants, airlines, and discretionary goods. In the near-term, we anticipate relatively flat markets as we await the outcome of impeachment proceedings, Biden's inauguration, and vaccine distribution. In the next 3-6 months, we expect to see the markets take a breather, declining 5 to 10% before recovering. By the end of 2021, we expect the stock market to be above its current highs again. With the assumption that bond interest rates will remain near (or below) zero, we will continue to prioritize stocks and inflation-adjusted securities in our client portfolios. Want to get involved?You already signed up for the newsletter, so you're on the right track! For all of 2021, we will be managing any client account with less than $3,000 for FREE! All we ask is that you set up automatic contributions so you can hit your savings goals for the year. Think of it as a free trial, except we're actively trying to get you out of the free service by growing your savings. If we can't do it, it stays free until we do!If you're interested, feel free to schedule a Free Discovery Meeting.I hope you have a wonderful rest of your January and beyond. 

Warm regards,

Nate Hoskin, Chief Investment OfficerHoskin Capital, LLC